Israel
-
How Pitango VC Is Planning to Invest Its New $175M Health Tech Fund
Pitango Venture Capital, one of the largest venture capital firms in Israel, announced the first closing of a new $175 million healthcare technology fund. With the new fund, the firm plans to build a portfolio of approximately 15 new companies over a period of three to four years.
-
Devices & Diagnostics, Artificial Intelligence
FDA Clearance Spotlight: UltraSight
UltraSight, based in Israel, recently received a nod from the FDA to market its UltraSight AI Guidance product that can assist medical professionals without sonography experience in acquiring cardiac ultrasound images and allow for more widespread detection of heart diseases.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
New Israeli Health Tech Fund Launches to Invest in Pre-Seed and Seed-Stage Startups
Israeli health tech fund Shoni Health Ventures recently launched to invest in digital health and medical device startups that are in the pre-seed and seed stages of fundraising. The fund is affiliated with Sheba Medical Center, the largest hospital in Israel. Startups will have access to the hospital’s innovation center so that they can develop, pilot and commercialize their products.
-
Startup with bold goal to establish digital biomarkers for neurological disease diagnosis wins $25M
NeuraLight just raised $25 million in its bid to create new, digital endpoints that can be used by clinicians and researchers to objectively measure neurological conditions with the ultimate goal – still several years away – to have the company’s technology serve as the gold standard for neurological evaluation.
-
Four big pharma companies team up in AI initiative focused on drug R&D
A new startup initiative in Israel aims to create and invest in startups that use artificial intelligence to address challenges in drug discovery and development. Called AION Labs, this innovation lab stems from an economic development effort from the Israeli government and will have contributions from AstraZeneca, Merck, Pfizer and Teva Pharmaceutical.
-
Antidote Health nabs $12M in seed round to grow AI-driven virtual HMO
The company offers clinical triage via an artificial intelligence-powered chatbot and unlimited virtual visits through a majority of its plans. Inspired by the Israeli healthcare system, patients on Antidote plans pay a monthly membership fee.
-
Israeli-founded telehealth company aims to provide antidote to unaffordability of US healthcare
A new telehealth company, called Antidote, is taking aim at rising healthcare costs in the U.S. by providing an alternative inspired by the healthcare system in Israel. For a monthly membership fee, Antidote users gain unlimited virtual visits and zero copays on most medications.
-
Artificial Intelligence, Diagnostics
AI algorithm for detecting prostate cancer shows more than 98% sensitivity, 97% specificity in study
Tel Aviv-based Ibex Medical Analytics published data on what it called the first algorithm to go beyond detection and into areas like tumor grading and sizing.
-
Israel’s Arkin Holdings raises $140M for second life sciences investment fund
The company, based near Tel Aviv, said it plans to invest money from the fund, Arkin Bio-Ventures II, in areas like gene therapy, as well as RNA- and DNA-targeted drugs.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Startups, Artificial Intelligence, Health Tech
Symptom checker K Health raises $48M
K Health, a startup that lets patients look up their symptoms and chat with a doctor, raised $48 million in funding.
-
Israeli fingerprick blood testing company gets FDA clearance for CBC analyzer
With the regulatory nod, Sight Diagnostics can have its computer-vision powered blood analyzer be sold to hospital labs to provide lab-grade results within 10 minutes on just two drops of blood.
-
Artificial Intelligence, Diagnostics
Startup says algorithm identifies new risk factor for heart disease but a doctor is skeptical
The algorithm — which measures variations in heart rate — is designed to predict heart problems, but a cardiologist wonders whether it can outperform other risk factors.
-
Devices & Diagnostics, Telemedicine
Tyto Care takes telehealth retail
The Israeli maker of FDA-cleared medical devices announced it has expanded its partnership with Best Buy such that its connected device kit – TytoHome – is sold in the retailer’s U.S. locations.
-
89Bio goes public and the stock price surges
89Bio, a biopharma company developing a drug to treat NASH, went public on Monday and saw its stock increase beyond the $16 per share it had opened with.
-
Startups, Devices & Diagnostics, Health Tech
New $100M fund to invest in pre-revenue medical device and digital health startups
This is the fourth fund launched by Accelmed, a group of funds based in Israel and New York, which currently manages more than $300 million.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
